Delaware Clinical and Translational Research ACCEL Program-Admin Core

特拉华州临床和转化研究 ACCEL 计划-管理核心

基本信息

  • 批准号:
    10437678
  • 负责人:
  • 金额:
    $ 130.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-25 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract—Administrative The DE-CTR ACCEL Program (ACCEL), was launched in September of 2013 and brought together four institutions with complementary missions to dramatically strengthen the clinical and translational research capabilities within and across all of our partner institutions. These institutions are: the University of Delaware (lead institution) (UD), Christiana Care Health System (CCHS), and Nemours/ Alfred I. duPont Hospital for Children (Nemours), and the Medical University of South Carolina (MUSC). One of the more exciting aspects of this application is the additional of Delaware State University (DSU), an American historically black, public university located in Dover, Delaware, to the ACCEL Program. The planned components of the ACCEL Program will include the Administrative Core and the five other required Key Component Activities (KCAs), including: the Professional Development (PD) Core; the Biostatistics, Epidemiology, & Research Design (BERD) Core; the Community Engagement & Outreach (CEO) Core; the Pilot Project Program, and the Tracking and Evaluation (T&E) Core. This represents only a modest change from our current program. We believe that the Administrative Core has served the ACCEL Program well during over the past four years. The Administrative Core has provided the infrastructure and resource to allow each of the components to make sub- stantial and meaningful progress. At the center of the Administrative Core is the ACCEL Steering Committee. The committee members, which represent each of the participating institutions, meet weekly either in person or via Blue- Jeans videoconferencing to discuss all substantive funding and programmatic decisions that need to be made by the PI. This stricter has allowed us to build a strong partnership across institutions based on trust, mutual respect, and common interests. The overall goal of the Administrative Core is to further increase the productivity and impact of each of ACCEL’s components and contribute to the overall IDeA-CTR goals. The Specific Aims of the Administra- tive Core are to continue to: 1) Provide a flexible and efficient administrative and governance structure that ensures sound fiscal management and compliance with all federal, state and local regulations and promotes collaboration and open communication across all ACCEL components, participating institutions, and other IDeA programs within Delaware and across the nation. 2) Facilitate the recruitment of outstanding clinical and translational faculty to each institution; 3) Monitor the progress of each component and take appropriate steps to ensure the overall success of the ACCEL program; and 4) Work with the NIGMS program staff and the other CTR programs to ensure that ACCEL effectively contributes to the National IDeA-CTR goals. We are excited to continue to work together to grow the ACCEL Program to include DSU and to see what can be accomplished over the next five years.
摘要 - 管理 DE-CTR ACCEL计划(ACCEL)于2013年9月启动,汇集了四个研究所 具有编译任务,以急剧的力量力量转运研究能力内部 在我们所有的合作伙伴研究所中。 Christiana Care Health System(CCHS)和Nemours/ Alfred I. Dupont儿童医院(Nemours)和Thee 南卡罗来纳州医科大学(MUSC)。 特拉华州立大学(DSU),美国历史悠久的黑人公立大学,位于特拉华州多佛 加速计划。 其他五个必需的关键组成活动(KCAS),包括:专业发展(PD)核心; 生物统计学,流行病学和研究设计(BERD)核心; 飞行员项目计划以及跟踪和评估(T&E)核心仅代表适度的变化。 我们当前的程序。 我们认为,在过去的四年中,行政核心在加速计划中都很好 行政核心已证明了基础架构和资源,以使每个组件都可以使子部分 行政核心的Stantial和含义进度是加速指导委员会 代表每个参与机构的委员会成员亲自或通过蓝色会议 牛仔裤的视频会议讨论所有实质性资金和程序化的决定,需要由某些人做出 PI。 共同利益。行政核心的总体目标是进一步提高 加速的每个组件都为整体Idea-CTR目标做出了贡献。 核心将继续:1)提供灵活,效率和管理结构,以确保 合理的财政管理和与所有联邦,州和地方法规的复合汇编,并促进合作 以及在所有加速组件,参与结构和其他想法计划中的开放沟通 特拉华州和全国2) Intinition; 3)监视每个组件的进度,并采取适当的步骤 加速计划和4)与裸体计划人员和其他CTR计划一起工作 有效促进了国家思想-CTR目标。 我们很高兴继续共同努力,以增长加速程序,以包括DSU并查看可以是什么 在接下来的五年中完成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory E Hicks其他文献

Gregory E Hicks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory E Hicks', 18)}}的其他基金

Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
  • 批准号:
    10686197
  • 财政年份:
    2022
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10437677
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10885455
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
  • 批准号:
    10892513
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10841849
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10721011
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10372245
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
  • 批准号:
    10728055
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
  • 批准号:
    10721012
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10223322
  • 财政年份:
    2013
  • 资助金额:
    $ 130.48万
  • 项目类别:

相似海外基金

Building predictive algorithms to identify resilience and resistance to Alzheimer's disease
构建预测算法来识别对阿尔茨海默病的恢复力和抵抗力
  • 批准号:
    10659007
  • 财政年份:
    2023
  • 资助金额:
    $ 130.48万
  • 项目类别:
Leveraging Spatial Epidemiology to Reduce Hypertension Disparities
利用空间流行病学减少高血压差异
  • 批准号:
    10855071
  • 财政年份:
    2023
  • 资助金额:
    $ 130.48万
  • 项目类别:
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
明尼苏达大学临床与转化科学研究所 (UMN CTSI)
  • 批准号:
    10763967
  • 财政年份:
    2023
  • 资助金额:
    $ 130.48万
  • 项目类别:
HCC Ovarian Cancer SPORE
HCC 卵巢癌孢子
  • 批准号:
    10713050
  • 财政年份:
    2023
  • 资助金额:
    $ 130.48万
  • 项目类别:
HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS
艾滋病毒和药物使用队列协调中心新兴和高影响科学跨队列研究:艾滋病毒成功
  • 批准号:
    10676432
  • 财政年份:
    2023
  • 资助金额:
    $ 130.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了